Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atossa Genetics Inc (NQ: ATOS )

1.550 USD +0.030 (+1.97%)
Official Closing Price Updated: 7:57 PM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,486,689
Open 1.520
Bid (Size) 1.530 (5)
Ask (Size) 1.550 (9)
Prev. Close 1.520
Today's Range 1.490 - 1.650
52wk Range 0.8100 - 5.080
Shares Outstanding 120,824,368
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA’s Expanded Access Pathway
April 08, 2021
From GlobeNewswire News Releases
Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update
March 31, 2021
From GlobeNewswire News Releases

Performance

YTD
+63.16%
+63.16%
1 Month
-38.00%
-38.00%
3 Month
+9.93%
+9.93%
6 Month
-19.69%
-19.69%
1 Year
-27.91%
-27.91%

More News

Read More
Physician-Scientist Steven Quay Provides Open Letter Response to WHO Report: Five Undisputed Facts Support the Laboratory Origin of the COVID Virus
March 30, 2021
From PR Newswire
4 Biotech Penny Stocks on Robinhood You’ll Want To Watch In 2021
March 31, 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Atossa Therapeutics Announces Pricing of $50.0 Million Registered Direct Offering Priced At-The-Market
March 22, 2021
From GlobeNewswire News Releases
Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19
March 12, 2021
From ACN Newswire
Atossa Therapeutics Announces Receipt of FDA Safe to Proceed Letter for Treatment of an Ovarian Cancer Patient with Oral Endoxifen Under Expanded Access Pathway
March 11, 2021
From GlobeNewswire News Releases
Interesting ATOS Put And Call Options For June 18th
April 16, 2021
Tags Stocks
From Market News Video
4 High-Volume Penny Stocks For Your March Watch List
March 09, 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19
February 25, 2021
From GlobeNewswire News Releases
Top Penny Stocks To Buy Right Now? 4 To Watch After A Pullback
February 25, 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media